
Category: Pharma Industry
BREAKING: Developments in 340B Contract Pharmacy Lawsuit
Ryan White Clinics for 340B Access (RWC-340B) late yesterday asked a federal district court to issue a temporary restraining order (TRO) and preliminary injunction requiring U.S. Health and Human Services (HHS)
Read More »Novartis Retreats, But Not Entirely, on 340B Contract Pharmacy (Update 2)
Update 2, Friday Oct. 30, 4:00 p.m. EDT—Hospital group 340B Health said Novartis’ action was inexcusable.
Read More »Lilly’s Letter to HRSA on Why it Thinks 340B Contract Pharmacy is Unlawful
Drug manufacturer Eli Lilly and Co. on May 18 gave the U.S. Health Resources
Read More »Iowa’s U.S. Senators Meet With HHS Top Brass About Pharma’s 340B Moves
Both of Iowa’s U.S. senators met yesterday with “top officials” at the U.S. Health and
Read More »Health Centers Sue HHS Over Drug Company Denials of 340B Pricing
This is a developing story. Check the online version for possible updates.
The National Association of
Read More »HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks
Activists aligned with the powerful grassroots group AIDS Healthcare Foundation (AHF) marched yesterday in front of drug manufacturer AstraZeneca’s Wilmington, Del., headquarters building to protest the company’s decision effective Oct.
Read More »